Physician profile
Meihui Ma
NPI 1487679569
$2,529.24
in general payments reported to CMS, 2019-2025
22 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $229 · 2021: $247 · 2022: $152 · 2023: $98.59 · 2024: $174 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348 · Education: $47.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.11 |
| Education | $47.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $647.73 | 2019-2025 | Ultomiris |
| Biogen, INC. | $466.08 | 2019-2023 | Vumerity |
| Emd Serono, INC. | $243.19 | 2019 | |
| Supernus Pharmaceuticals, INC. | $207.26 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $107.86 | 2019-2024 | |
| Abbvie INC. | $106.87 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $103.89 | 2019 | |
| Genentech USA, INC. | $94.21 | 2019-2022 | |
| Genzyme Corporation | $90.77 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $87.64 | 2019 | |
| Ceribell, INC. | $59.87 | 2020 | |
| Acorda Therapeutics, INC | $50.75 | 2019 | |
| Ucb, INC. | $49.64 | 2019-2024 | Briviact |
| Allergan, INC. | $45.19 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $40.37 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $29.76 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.46 | 2022 | |
| Csl Behring | $16.26 | 2019 | |
| Amgen INC. | $15.95 | 2019 | |
| Medtronic USA, INC. | $15.46 | 2019 | |
| Acadia Pharmaceuticals INC | $14.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meihui Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.